Drug intelligence / Profile preview

Cavilon No Sting Barrier Film

Development stage
Unknown
Lead developer
3M
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Cavilon (specifically Cavilon No Sting Barrier Film) is a liquid barrier film developed by 3M that forms a transparent, breathable, and waterproof protective coating on the skin. It is composed of a unique blend of polymers, primarily an acrylate terpolymer, dissolved in a fast-drying, non-stinging solvent system consisting of hexamethyldisiloxane and isooctane. The film is designed to protect intact or damaged skin from body fluids, adhesive trauma, friction, and incontinence-associated dermatitis (IAD). In the context of oncology, it is used prophylactically to reduce the incidence and severity of radiodermatitis in patients undergoing radiotherapy for cancers such as breast cancer. Unlike traditional ointments or creams, it does not require removal and does not interfere with the adhesion of medical tapes or dressings.

Brand names
CavilonCavilon No Sting Barrier Film赛肤润
Other names
3M CavilonNo Sting Barrier Film

Beyond the preview

Go deeper on Cavilon No Sting Barrier Film.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cavilon No Sting Barrier Film.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call